TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/21/2025
Back to search
Official data from USPTO
BIOHM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
10/26/2025
Trademark type
Word
Nice classes
5
Filing date
12/20/2016
Registration date
07/31/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2025
Last transaction
10/26/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2017
First use in commerce
03/01/2017
Drawing code
4
Owner type
99
Owner location
CLEVELAND, OH
Examiner
STINSON,JENNIFER ELLE
Current location
Historical data usage
Holders and representatives
Holders
BIOHM HEALTH INC.
BIOHM HEALTH LLC
PathoBiome LLC
Representatives
Lisa C. Pavento Meunier Carlin & Curfman LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplementsprobiotic compositions; nutritional supplementscarbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powdertabletliquidcapsule or spray form; mineral supplements in powdertabletliquidcapsule or spray form; dietary supplements in powdertabletliquidcapsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; herbal supplements for general health and well-beingin powdertabletliquidcapsule or spray form; nutritional supplementsprobiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosisvaginal discharge and odorsfor preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odorkilling bacteria that cause bacterial vaginosisfor maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical uselactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical productsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humansreducing inflammation and pain; dietary supplements for medical usebaby foodall the above containing preparations and products resulting from the processing of microorganismsparticularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplementsnutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Diseaseulcerative colitis and irritable bowel syndrome
Publications
History of USPTO decisions and trademark events.
53 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/21/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/21/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/02/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/02/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/31/2024
E815
TEAS SECTION 8 & 15 RECEIVED
07/31/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/31/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/15/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/22/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/22/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/22/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/22/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/22/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/22/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/31/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/26/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/25/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/31/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/31/2018
IUAF
USE AMENDMENT FILED
05/09/2018
EISU
TEAS STATEMENT OF USE RECEIVED
05/09/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/01/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2018
PUBO
PUBLISHED FOR OPPOSITION
03/06/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/04/2017
GNSL
LETTER OF SUSPENSION E-MAILED
11/04/2017
CNSL
SUSPENSION LETTER WRITTEN
11/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/16/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/25/2017
GNRT
NON-FINAL ACTION E-MAILED
09/25/2017
CNRT
NON-FINAL ACTION WRITTEN
09/25/2017
RMRF
REMOVE FROM TEASRF
09/25/2017
ACEC
AMENDMENT FROM APPLICANT ENTERED
08/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2017
ALIE
ASSIGNED TO LIE
08/28/2017
PAPER RECEIVED
08/08/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/17/2017
GNSL
LETTER OF SUSPENSION E-MAILED
07/17/2017
CNSL
SUSPENSION LETTER WRITTEN
07/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/27/2017
GNRT
NON-FINAL ACTION E-MAILED
03/27/2017
CNRT
NON-FINAL ACTION WRITTEN
03/27/2017
DOCK
ASSIGNED TO EXAMINER
03/21/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/28/2016
Continuous trademark protection
Get notified about every new filing that threatens BIOHM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.